ADMA Biologics Inc
NASDAQ:ADMA
ADMA Biologics Inc
NASDAQ:ADMA
Price:
9.485 USD
0.05%
Market Closed
Updated:
Jun 1, 2024
ADMA Biologics Inc
Net Issuance of Common Stock
|
ADMA Biologics Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADMA Biologics Inc
NASDAQ:ADMA
|
Net Issuance of Common Stock
$2.1m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADMA Biologics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
2.1m
USD
2.1m
USD
Based on the financial report for Mar 31, 2024, ADMA Biologics Inc's Net Issuance of Common Stock amounts to 2.1m USD.
What is ADMA Biologics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
-71%
-71%
The average annual Net Issuance of Common Stock growth rates for ADMA Biologics Inc have been -71% over the past three years .
You don't have any saved screeners yet
